Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cellsTsuyoshi Ohta, Hirohisa Kurachi, Noriko Henmi et al.|Cancer Biology & Therapy|2012Cited by 55
Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cellsTsuyoshi Ohta, Hirohisa Kurachi, Masahide Ohmichi et al.|Cancer Biology & Therapy|2012Cited by 19